Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.
Lauren M. Zhao, BA
Advertisement
Articles by Lauren M. Zhao, BA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
PBM Reform and Supportive Care Needs: Nicolas Ferreyros
2
5 Things to Know About the One Big Beautiful Bill Act
3
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
4
Genetic Analysis Links Insomnia Liability to Higher Inflammation Marker
5